4.4 Article

Metabolic rates, growth phase, and mRNA levels influence cell-specific antibody production levels from in vitro-cultured mammalian cells at sub-physiological temperatures

期刊

MOLECULAR BIOTECHNOLOGY
卷 39, 期 1, 页码 69-77

出版社

HUMANA PRESS INC
DOI: 10.1007/s12033-008-9032-0

关键词

cold-shock; sub-physiological temperature culturing; CHO; NS0; mRNA levels; monoclonal antibody production

资金

  1. BBSRC [BB/D009375/1] Funding Source: UKRI
  2. Biotechnology and Biological Sciences Research Council [BB/D009375/1, BB/C006569/1] Funding Source: researchfish
  3. Biotechnology and Biological Sciences Research Council [BB/D009375/1, BB/C006569/1] Funding Source: Medline

向作者/读者索取更多资源

Previous work has shown that recombinant protein yield can be improved from in vitro-cultured mammalian cells by culturing at sub-physiological temperatures, although this effect is cell line and product dependent. The mechanism(s) by which low temperature leads to enhanced product yield are currently unknown; however, recent reports suggest that increased mRNA levels at sub-physiological temperatures may be largely responsible for this. Here, we have investigated whether low-temperature cultivation of cell lines selected for antibody production at 37C leads to changes in heavy- and light-chain mRNA levels and if this is reflected in antibody yields. Low-temperature in vitro culturing resulted in reduced viable cell concentration, prolonged cell viability, a reduction in metabolite consumption and production, cell cycle arrest in both CHO and NS0 cells, and changes in the levels of heavy- and light-chain mRNA. Despite increases in the level of heavy- and light-chain mRNA upon culturing at 32C in our model CHO cell line, this did not result in increased total product yield; however, changes in cell-specific yields were observed that reflected the metabolic rate of glucose utilization and changes in mRNA levels.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biotechnology & Applied Microbiology

Constitutively active Rheb mutants [T23M] and [E40K] drive increased production and secretion of recombinant protein in Chinese hamster ovary cells

Stuart P. De Poi, Jianling Xie, C. Mark Smales, Christopher G. Proud

Summary: The study demonstrates that expressing certain constitutively active mutants of Rheb in CHO cells can lead to faster protein synthesis and increased secretion of valuable proteins, providing a simple approach to promoting cell growth and production of high commercial value secreted proteins in defined media.

BIOTECHNOLOGY AND BIOENGINEERING (2021)

Article Biotechnology & Applied Microbiology

Selection of CHO host and recombinant cell pools by inhibition of the proteasome results in enhanced product yields and cell specific productivity

Tanya J. Knight, Sarah Turner, Colin M. Jaques, Mark Smales

Summary: CHO cells are widely used for recombinant protein production, but some proteins are difficult to express in this system. This study found that proteasome activity in CHO cells is linked to their ability to produce recombinant proteins, and applying proteasome inhibitors during cell pool construction can enhance productivity of recombinant cell lines expressing difficult-to-express proteins.

JOURNAL OF BIOTECHNOLOGY (2021)

Article Biotechnology & Applied Microbiology

Engineering of Chinese Hamster Ovary Cells With NDPK-A to Enhance DNA Nuclear Delivery Combined With EBNA1 Plasmid Maintenance Gives Improved Exogenous Transient Reporter, mAb and SARS-CoV-2 Spike Protein Expression

James D. Budge, Robert J. Young, Christopher Mark Smales

Summary: Transient gene expression in mammalian cells relies on efficient DNA delivery into the nucleus, which can be enhanced by NDPK-A protein with NLS. Co-expression of NDPK-A and EBNA-1 with oriP elements leads to improved transient recombinant protein yields despite attenuated cell growth. Combining these technologies results in superior protein yields compared to using either approach independently.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)

Review Biotechnology & Applied Microbiology

Strategies to control therapeutic antibody glycosylation during bioprocessing: Synthesis and separation

Elizabeth Edwards, Maria Livanos, Anja Krueger, Anne Dell, Stuart M. Haslam, C. Mark Smales, Daniel G. Bracewell

Summary: Glycosylation plays a critical role in the quality and characteristics of therapeutic monoclonal antibodies in biologic manufacturing. Advances have been made in upstream processing, such as mammalian cell line engineering, to improve the predictability of glycosylation. Downstream processing strategies, including the use of novel technologies, are also being explored to control glycosylation. However, more research is needed to establish holistic and consistent manufacturing processes for antibody therapies.

BIOTECHNOLOGY AND BIOENGINEERING (2022)

Review Biochemical Research Methods

Analytics of host cell proteins (HCPs): lessons from biopharmaceutical mAb analysis for Gene therapy products

Daniel G. Bracewell, Victoria Smith, Mike Delahaye, Mark C. Smales

Summary: The article discusses the development of HCP analysis and how insights from therapeutic monoclonal antibody preparations can inform the analysis of gene therapy viral vector products. While mass spectrometry approaches for HCP analysis in viral vector preparations have been established, they are yet to be widely applied in process or host cell line development. As these technologies are implemented and data becomes available, it will accelerate process development activities.

CURRENT OPINION IN BIOTECHNOLOGY (2021)

Review Biochemical Research Methods

Exosomes: Biogenesis, targeting, characterization and their potential as Plug & Play vaccine platforms

Laura E. Dyball, C. Mark Smales

Summary: Exosomes are small spherical vesicles released into the extracellular environment via fusion of multivesicular bodies (MVBs) to the plasma membrane. They are involved in various physiological processes and have potential as biomarkers and therapeutic agents. However, there is still limited understanding of exosome biogenesis, manufacturing, characterization, and application methods.

BIOTECHNOLOGY JOURNAL (2022)

Letter Dermatology

Eukaryotic Elongation Factor 2 Kinase Activity Is Required for the Phenotypes of the Rpl24Bst Mouse

John R. P. Knight, Christopher G. Proud, Giovanna Mallucci, Tobias von der Haar, C. Mark Smales, Anne E. Willis, Owen J. Sansom

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Biotechnology & Applied Microbiology

Manipulation of mRNA translation elongation influences the fragmentation of a biotherapeutic Fc-fusion protein produced in CHO cells

Tanya J. Knight, Jane F. Povey, Davide Vito, Atul Mohindra, Colin M. Jaques, C. Mark Smales

Summary: In this study, the site of fragmentation of a model immunoglobulin G1 Fc-fusion protein was identified, and the observed clipping and aggregation were reduced by lowering the temperature and adding chemical reagents. The findings suggest that manipulating mRNA translation can improve protein folding and reduce the susceptibility to fragmentation.

BIOTECHNOLOGY AND BIOENGINEERING (2022)

Article Biotechnology & Applied Microbiology

Knowledge elicitation as a route to understanding the decision making landscape in monoclonal antibody manufacturing

Gary Montague, Olga Obrezanova, John Liddell, Alison Turner, Suzanne Aldington, Jamie Graham, Andy Racher, Susanne Joerg

Summary: This paper discusses a strategy for identifying decisions and bottlenecks in monoclonal antibody development and introduces a knowledge acquisition technique to enhance decision-making and understanding of the development supply chain.

FOOD AND BIOPRODUCTS PROCESSING (2022)

Article Biochemistry & Molecular Biology

Evaluating data integrity in ribosome footprinting datasets through modelled polysome profiles

Fabio Hedayioglu, Emma J. Mead, Patrick B. F. O'Connor, Matas Skiotys, Owen J. Sansom, Giovanna R. Mallucci, Anne E. Willis, Pavel Baranov, C. Mark Smales, Tobias von der Haar

Summary: The study validates two experimental tools for assessing ribosome binding to mRNAs, highlighting the usefulness of polysome profile reconstructions in evaluating dataset quality.

NUCLEIC ACIDS RESEARCH (2022)

Article Biotechnology & Applied Microbiology

A ubiquitous amino acid source for prokaryotic and eukaryotic cell-free transcription-translation systems

Lakshmeesha K. Nagappa, Wakana Sato, Farzana Alam, Kameshwari Chengan, Christopher M. Smales, Tobias von der Haar, Karen M. Polizzi, Katarzyna P. Adamala, Simon J. Moore

Summary: Cell-free gene expression systems are important tools in synthetic biology and industrial production. This study discovered a new, low-cost and widely available amino acid source that can replace commercial ones in these systems. The method is applicable to various cell-free gene expression systems.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

Editorial Material Biotechnology & Applied Microbiology

Editorial: Characterization of biotherapeutic products

Anurag S. Rathore, C. Mark Smales, Andras Guttman

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

Review Biochemistry & Molecular Biology

Translation of in vitro-transcribed RNA therapeutics

Tobias von der Haar, Thomas E. Mulroney, Fabio Hedayioglu, Sathishkumar Kurusamy, Maria Rust, Kathryn S. Lilley, James E. Thaventhiran, Anne E. Willis, C. Mark Smales

Summary: In vitro transcribed, modified messenger RNAs (IVTmRNAs) have been widely used for COVID-19 vaccination and are being explored for other therapeutic applications. However, differences in genesis pathways, cell entry routes, and modifications affect how IVTmRNAs interact with cellular machinery and how efficiently they are translated. Understanding the similarities and differences in translation between IVTmRNAs and native mRNAs is crucial for improving their therapeutic efficacy.

FRONTIERS IN MOLECULAR BIOSCIENCES (2023)

Article Biotechnology & Applied Microbiology

A proline metabolism selection system and its application to the engineering of lipid biosynthesis in Chinese hamster ovary cells

James D. Budge, Joanne Roobol, Gurdeep Singh, Theo Mozzanino, Tanya J. Knight, Jane Povey, Andrew Dean, Sarah J. Turner, Colin M. Jaques, Robert J. Young, Andrew J. Racher, C. Mark Smales

Summary: CHO cells are commonly used to produce complex recombinant biotherapeutics like monoclonal antibodies. A selection marker system based on the metabolic needs of CHO cells for proline production has been developed to enhance recombinant protein productivity through engineering lipid metabolism.

METABOLIC ENGINEERING COMMUNICATIONS (2021)

暂无数据